Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-10
2011-11-15
Morris, Patricia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S318000, C514S336000, C514S253010, C544S124000, C544S360000, C546S194000, C546S281400
Reexamination Certificate
active
08058271
ABSTRACT:
Described herein are compounds that are useful as ROCK inhibitors. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including cardiovascular, inflammatory, neurological, or proliferative diseases or disorders.
REFERENCES:
patent: 03/062215 (2003-07-01), None
patent: 2004/041813 (2004-05-01), None
patent: 2005/074642 (2005-08-01), None
patent: 2005/100342 (2005-10-01), None
Dorwald , Side Reactions in Organic Synthesis, 2005, Wiley: VCH Weinheim Preface, pp. 1-15 & Chapter 8, pp. 279-308.
Bandarage Upul
Cao Jingrong
Come Jon
Green Jeremy
Marhefka Craig
Morris Patricia
Pearson Daniel A.
Vertex Pharmaceuticals Incorporated
LandOfFree
Selective inhibitors of rock protein kinase and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective inhibitors of rock protein kinase and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective inhibitors of rock protein kinase and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4298740